Biocomposites, a medical devices company that engineers, manufactures and markets products for regenerating bone and managing infection in bone and soft tissue, has entered into a multi-year agreement with Zimmer Biomet to exclusively distribute genex Bone Graft Substitute with its new mixing system and delivery options in the U.S. orthopaedic market.
genex Bone Graft Substitute is a biphasic composite of that is specifically formulated to balance osteoconductive scaffold strength and persistence in the body to enable the optimal remodelling of bone architecture.
As part of the new agreement, genex has been upgraded for the U.S market to include a new closed-mixing system, to shorten preparation time and extend working time. It includes a more comprehensive set of delivery options added to allow a surgeon to inject, mould or prepare beads in accordance with their chosen technique.
genex Bone Graft Substitute’s 50:50 biphasic composition of calcium sulphate and β-tricalcium phosphate is not the only performance factor. It also has a negatively charged surface chemistry that has demonstrated a favourable osteogenic bone growth response up to five times normal (positively charged) levels, InVitro. The proprietary recrystallisation and purification production methods give genex its distinct properties and removes slow and non-absorbing compounds, such as hydroxyapatite, to ensure that it is completely absorbed and remodelled within 12 months.
Michael Harris, chief executive officer of Biocomposites, said: “I am delighted we are partnering with Zimmer Biomet to deliver our new genex Bone Graft Substitute product to the U.S. market. genex is already used and valued by surgeons in over 30 countries, including the US, undertaking 15,000 cases each year. The upgraded offering which we are providing to Zimmer Biomet will further benefit many more physicians and patients across the U.S.”
Brian Hatcher, president of Zimmer Biomet’s CMFT, foot & ankle and trauma added: “We are excited to partner with Biocomposites to bring the new genex Bone Graft Substitute kits to surgeons as we continue to advance our mission to alleviate pain and improve the quality of life for people around the world.”
